Our end of year appeal is here and we need your support! Donate today.
syringe and bottle

Hastings Center News

Mildred Solomon on Controversial Duchenne Drug Approval

Published Posted in Health and Health Care

Writing in the Health Affairs Blog, Hastings Center president Mildred Solomon says that the Food and Drug Administration’s controversial decision to approve the first drug for Duchenne muscular dystrophy is defensible, but only if there is adequate follow through. Read the post here.